Units of measure in clinical information systems.

The authors surveyed existing standard codes for units of measures, such as ISO 2955, ANSI X3.50, and Health Level 7's ISO+. Because these standards specify only the character representation of units, the authors developed a semantic model for units based on dimensional analysis. Through this model, conversion between units and calculations with dimensioned quantities become as simple as calculating with numbers. All atomic symbols for prefixes and units are defined in one small table. Huge permutated conversion tables are not required. This method is also simple enough to be widely implementable in today's information systems. To promote the application of the method the authors provide an open-source implementation of this method in JAVA. All existing code standards for units, however, are incomplete for practical use and require substantial changes to correct their many ambiguities. The authors therefore developed a code for units that is much more complete and free from ambiguities.

Implementing HL7: from the standard's specification to production application.

A C++ implementation of the HL7 health-care data interchange standard was developed by automatic methods applied to the authoritative specification of the standard. The reusable class library thus created presents an intuitive, flexible, and easy-to-use application programming interface to the HL7 protocol. This allows HL7 applications to be developed quickly while a high conformance to the standard is ensured.

[Cardiac effects of atropine in patients treated with antidepressive medication]. / Kardiale Atropinwirkungen bei Patienten mit Antidepressiva-Medikation.

UNLABELLED: It is often suggested that atropine should be avoided in patients on treatment with tricyclic or tetracyclic antidepressants. It is feared that the strong anticholinergic side effects of these drugs could exaggerate the effects of atropine on the heart. METHODS: In a controlled prospective study, 31 patients on treatment with tri- or tetracyclic antidepressants were given atropine in incremental doses. ECG-changes and changes in heart rate were recorded and compared to a control group. Atropine 2 micrograms/kg was administered in 60 sec. intervals up to a total dose of 10 micrograms/kg. RESULTS: The patients on antidepressant treatment had a higher incidence of common anticholinergic side effects (dryness of mouth, accommodation disorders, constipation) due to the anticholinergic properties of the antidepressants. In addition, the basal heart rate of these patients was significantly higher compared to the control group (81/min vs. 73/min). After administration of 2 and 4 micrograms/kg of atropine the patients of the control group showed a 5% resp. 4% decrease in heart rate. 26% of these patients developed conduction disturbvances. These changes could be explained by the parasympathetic effect of low doses of atropine. They were less pronounced in the patients on treatment with antidepressants. Here, only the administration of 2 micrograms/kg of atropine led to a 2% decrease in heart rate. Only 6% of these patients developed conduction disturbances. Both groups showed an increase in heart rate when higher doses of atropine were administered (8 and 10 micrograms/kg). However, the increase in heart rate after administration of 10 micrograms/kg was significantly less in the patients on antidepressant treatment compared to the control group (11.4% vs. 16.2%). There were no changes of blood pressure during these investigations. CONCLUSION: The results of this study suggest that the anticholinergic properties of tri- and tetracyclic antidepressants include an increase in basal heart rate, but do not render the heart more susceptible to the cardiac effects of atropine.

[Perioperative cardiovascular reactions and the noradrenaline plasma level in patients on chronic antidepressant medication]. / Perioperative Kreislaufreaktionen und Noradrenalin-Plasmaspiegel bei antidepressiver Dauermedikation.

UNLABELLED: It is still controversial whether the perioperative incidence of cardiovascular complications is increased in patients on chronic treatment with cyclic antidepressants (AD) and whether AD medication should be discontinued prior to surgery. METHODS. We measured perioperative cardiovascular variables in 31 patients on chronic treatment with tri- and tetracyclic AD and 31 patients without AD medication. Heart rate, blood pressure, and noradrenaline plasma concentrations were compared between the two groups at nine points in time. During induction of anaesthesia, the ECG was recorded continuously. After the administration of 0.01 mg/kg atropine i.v., all patients received opiate-supplemented enflurane anaesthesia. RESULTS: Re-uptake inhibition of noradrenaline by AD resulted in significantly higher noradrenaline plasma concentrations before and during anaesthesia in the AD-treated group. The incidence of arrhythmias, blood pressure elevations, and tachycardia was not increased in patients in AD treatment. Arrhythmias during induction of anaesthesia were seen in 6 of the AD-treated patients and 5 of the controls. Blood pressure elevations by more than 35% were seen in 10 patients on AD treatment and 8 controls. The heart rate prior to induction of anaesthesia and 2 h after the end of surgery was significantly higher in the AD-treated group. During anaesthesia the heart rate was higher at two points in time only. The incidence of tachycardia was similar in both groups. Intravenous administration of 0.01 mg/kg atropine prior to induction of anaesthesia increased the heart rate of the patients on chronic AD medication by 11.4%. This increase was significantly higher in the control group (16.2%), suggesting that patients with chronic AD treatment do not have a higher sensitivity to atropine. CONCLUSION: The elevated noradrenaline plasma levels in patients on chronic AD treatment did not result in a higher incidence of arrhythmias, blood pressure elevations, or tachycardia perioperatively. Taking these results into account, we do not consider it necessary to discontinue chronic AD medication prior to surgery in patients without cardiovascular disease.

[Long-term antidepressive medication-- an increased anesthetic risk?]. / Antidepressive Dauermedikation--ein erhöhtes Narkoserisiko?

Antidepressants inhibit the re-uptake of norepinephrine at the monoaminergic synapse from the synaptic fissure, leading in this way to an increased sensitivity to catecholamines. In addition, antidepressants have alpha1-, H1- and H2-receptor blocking effects and also anticholinergic effects; the tricyclic antidepressants in particular are known for these properties. A few animal experiments and some case reports indicate that a long-term treatment with these substances can lead to intra-operative blood pressure fluctuations, tachycardia and arrhythmias. Therefore a number of authors recommend that antidepressants be withdrawn 3 days before a planned operation. In view of the pharmacokinetics of these substances and the long-term adapting processes at the monoaminergic synapse this period is certainly too short to achieve complete loss of effectiveness. Other authors think preoperative withdrawal is not indicated if there is careful intraoperative monitoring. We agree with the latter opinion. Inhalation anesthesia with isoflurane or enflurane should be preferred. The muscle relaxant pancuronium should not be used, and exogenous intake of catecholamines should be avoided. Opiates seem to have a positive effect on cardiac stability. Benzodiazepines show the least interactions with antidepressants and are therefore recommended for premedication. In the postoperative period the possibility of an anticholinergic syndrome has to be considered.

[The effect of pre-oxygenation on hemodynamics and oxygen consumption]. / Einfluss der Präoxygenierung auf Hämodynamik und Sauerstoffverbrauch.

Pre-oxygenation is routinely used prior to anesthesia and intubation. In awake, premedicated patients scheduled for major aortic surgery we assessed the effects of breathing oxygen for 10 min via a loosely fitting face mask on hemodynamics and oxygen consumption (VO2). RESULTS. O2-breathing increased arterial PO2 to 51 +/- 13 kPa and decreased VO2 from 109 +/- 18 to 92 +/- 24 ml.min-1.m-2 (P less than 0.001 for both variables). This reduction of VO2 resulted from both a fall in cardiac index from 3.22 +/- 0.67 to 3.04 +/- 0.75 1.min-1/m-2 (P less than 0.05) and a decrease in arterio-venous oxygen content difference from 3.45 +/- 0.60 to 3.03 +/- 0.57 ml/dl (P less than 0.001). Systemic peripheral vascular resistance increased slightly from 1453 +/- 359 to 1538 +/- 383 dyne.s.cm-5.m-2 (P less than 0.05). CONCLUSIONS. These results indicate that an increase in F1O2 in patients without severe limitations of oxygen uptake by the lungs or oxygen transport to the tissues does not improve tissue oxygenation. We speculate that increased peripheral shunting acts to protect tissue PO2 during high arterial PO2 levels.

[The effect of thoracic peridural analgesia on the cortisol and glucose response in surgery of the abdominal aorta]. / Die Auswirkungen der thorakalen Periduralanalgesie auf die Kortisol- und Glukoseantwort bei Operationen an der abdominellen Aorta.

UNLABELLED: It has been shown that the stress response to lower abdominal surgery can be inhibited by epidural analgesia (EA). But EA seems to have little influence on the stress reaction to major abdominal surgery. The purpose of our study was to find out whether EA is able to diminish the cortisol and glucose response to major transabdominal surgery. METHODS: 31 patients undergoing elective surgery of the abdominal aorta were subdivided at random into 3 different anaesthesia groups: 1. halothane anesthesia, 2. neuroleptanalgesia (NLA) and 3. thoracic EA with bupivacaine (0.5%) in combination with a light general anesthesia. Some patients of each group received an intravenous infusion of 5% glucose. Blood samples were drawn before anesthesia, after intubation, 5 times during surgery and at the end of the operation and were analysed for cortisol and glucose. During the early postoperative period, 1, 2 and 24 h after surgery, only cortisol was measured. RESULTS: Only the glucose levels of patients who received no carbohydrate-containing infusion fluids were used for evaluation of the stress response. In the halothane group, there was a significant increase of the mean cortisol and glucose levels after the start of surgery. No intraoperative elevations of blood glucose and cortisol were seen in the EA group. Patients of the NLA group showed no hyperglycaemia and only mild elevations of the cortisol levels during the intraoperative period.(ABSTRACT TRUNCATED AT 250 WORDS)